ArcalystActive Ingredient(s): Rilonacept
FDA Approved: * February 27, 2008
Pharm Company: * REGENERON PHARMACEUTICALS
Rilonacept, sold under the brand name Arcalyst, is a medication used to treat cryopyrin-associated periodic syndromes, including familial cold autoinflammatory syndrome, and Muckle–Wells syndrome; deficiency of interleukin-1 receptor antagonist; and recurrent pericarditis. Rilonacept is an interleukin 1 inhibitor. Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellula... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.